The probiotic BI-04 may help reduce the risk of upper respiratory tract infections in healthy, active adults, according to a study.
Probiotics are beneficial bacteria (sometimes referred to as "friendly germs") that help to maintain the health of the intestinal tract and aid in digestion. They also help keep potentially harmful organisms in the gut (harmful bacteria and yeasts) under control. Most probiotics come from food sources, especially cultured milk products. Probiotics can be consumed as capsules, tablets, beverages, powders, yogurts, and other foods. Probiotic bacteria have been found to stimulate the body's immune system. They may also aid in several gastrointestinal illnesses such as inflammatory bowel diseases, antibiotic-related diarrhea, Clostridium difficile toxin-induced colitis, infectious diarrhea, hepatic encephalopathy, irritable bowel syndrome, and allergies.
Probiotics have been studied for the prevention of upper respiratory tract illnesses. The common cold, or acute viral nasopharyngitis, is a viral infection of the upper respiratory system, which may involve the nose, throat, sinuses, eustachian tubes (connects the ears to the throat), trachea (windpipe), larynx (voice box), and bronchial tubes (airways).
Colds are one of the leading causes of doctor visits and missed days from school and work. According to the Centers for Disease Control and Prevention (CDC), 22 million school days are lost annually in the United States as a result of the common cold. Over the course of a year, people in the United States suffer one billion colds, according to some estimates.
In the current study, researchers set out to determine whether supplementation with probiotics may impact illnesses of the respiratory system, stomach, or intestines in healthy, active men and women. They recruited 465 people with an average age of 35 and assigned them to one of three groups. The first group received the probiotic BI-04, the second group received the probiotic Bi-07, and the third group received a placebo mixed in a drink.
The results showed that the group that received BI-04 appeared to have a much lower risk of having an upper respiratory illness, compared to placebo. A significant difference in illness risk was lacking between the Bi-07 group and the placebo group. The BI-04 had the greatest delay in the time to an illness episode, compared to the other probiotic group and those who had received placebo.
The authors concluded that the probiotic Bl-04 appears to be a useful supplement in terms of helping to decrease the risk of upper respiratory tract infection in healthy, active adults.
Numerous other integrative therapies have been studied for the treatment of the common cold and other related illnesses. There is strong scientific evidence to support the use of andrographis, caffeine, and umckloabo for this purpose.
For more information about probiotics, please visit Natural Standard's Foods, Herbs & Supplements database.
The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2017 Natural Medicines Inc. Commercial distribution or reproduction prohibited. Natural Medicines is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.